Chapter 1425: Chapter 1068: A Disease with a 100% Mortality Rate Chapter 1425: Chapter 1068: A Disease with a 100% Mortality Rate Germany Berlin.

Professor Mainshtan still hasn’t come to his senses. He sits in his office, daydreaming, with a German-translated paper weighed down by a teacup on his desk–the paper is none other than Yang Ping’s on K-virus therapy.

As the head of the German translation team for the “Medicine” journal, Professor Mainshtan had translated Yang Ping’s paper into German on the very day it was published. Such is the immediacy of online paper dissemination; print publications simply cannot compete with this speed. On that day, the translated paper spread wildly within the German medical community.

The paper spread not only within the medical community but also, somehow, reached the ears of some tumor patients. Some of them called Professor Mainshtan’s laboratory to inquire about the details of K-virus therapy and hoped to schedule treatment. The laboratory’s phone lines were nearly overwhelmed, which left Professor Mainshtan at a loss for words.

He knew he should have translated it anonymously, without leaving his own name and the laboratory’s. Now he dare not set the lab phone down properly, instead leaving it aside.

Professor Mainshtan hadn’t yet digested the theory of spatial orientation genes, and now Professor Yang had come up with a K-virus therapy targeting tumors, which was a bit too much for him to handle.

What exactly is this? Professor Mainshtan pondered, amazed by its incredible capabilities.

This miraculous K-virus uses a recombinant adenovirus to implant a structure called the K-factor, with the adenovirus acting as a missile and the K-factor as its warhead. This “missile” carries the K-factor via blood circulation directly into the tumor. Once inside, the newly recombinant virus widely infects tumor cells, releasing the K-factor within the cells just as common viruses release viral particles. Once the K-factor is released, it can initiate the apoptotic program in tumor cells. Using this principle, it can kill tumor cells with immense precision, truly living up to the ideal of targeted therapy.

Marvelous!

Professor Mainshtan exclaimed.

Each step is ingeniously conceived, such as Professor Yang’s technique of recombinant adenovirus, which is unparalleled. He has genetically re-engineered the existing adenovirus, almost entirely avoiding its disadvantages while bringing its advantages to full fruition, setting a paradigm for the use of carrier viruses.

Adenovirus, as it originally was, has an extremely high infection rate for all cells within the body, almost 100%, which is the virus’s greatest strength. Yang Ping capitalized on this fact. If other viruses were used as carriers, they’d be unable to infect various cells and thus could not infect tumor cells. Without achieving infection, the subsequent step of killing tumor cells cannot even be contemplated.

Yang Ping has modified the recombinant virus to maintain a 100% infection rate in tumor cells, but the infection rate in other normal cells has been reduced. That is, it differentiates between tumor cells and normal cells, prioritizing tumor cells for infection.

The K-factor, which acts as the warhead, is a weapon that many tumor experts have longed for; countless teams worldwide are working on tumor therapy, hoping to obtain such factors. Yet, Yang Ping seems to have effortlessly resolved this.

If the concept of spatial orientation genes seem esoteric to most people, then the current K-virus therapy is very down-to-earth. Almost every oncology physician with professional training can understand it.

Professor Mainshtan rejuvenated, immediately called his assistant: “Book me a ticket to China!”

He was initially going to attend Yang Ping’s wedding, but now he decided to go earlier. He wanted to see for himself the actual state of this experiment–it’s incredibly exciting.

—
While the current adenovirus-based K-virus construction may not be the best configuration, it is definitely the optimal choice under current conditions. Other prototypes will be searched for later. With these few experiments, the K-virus therapy has basically taken shape. Although there are still many imperfections, it’s okay–they will be gradually perfected while simultaneously continuing treatment. Seeing hope in this, Sisi is now reassured by Yang Ping’s treatment plan, unlike before when she felt utterly helpless amid traditional therapies. Continuation of chemotherapy and radiotherapy without finding a solution would not only fail to cure but would accelerate the deterioration of her condition.

Yang Ping has prepared a treatment plan for Sisi, involving regular injections of the K-virus. Even if the virus successfully infects tumor cells after being injected into Sisi, it will still face attacks from the immune system. The virus can only replicate and resist these attacks for a longer time, but as time goes on, these viruses will ultimately be eliminated by the human immune system.

If there is no immunity against a virus, that is the most dangerous situation. Once it begins to cause destruction, the human body has no defense against it. Humans aren’t afraid of viruses that they’ve continuously dealt with, rather new ones are the concern.

For instance, viruses from permafrost or extraterrestrial viruses could be extremely dangerous once humans are infected since we have no immunity against these new threats. Without the experience to combat them, infection would mean death.

Yang Ping’s own blood test results, taken again, have come out–the virus has been completely eliminated, with no further detection of the virus. It seems that no matter how much the virus changes, it still primarily relies on the adenovirus gene, which determines its nature. Due to the mutation that appeared in Yang Ping, his immune system needed some time to adjust its battle plan and gradually eliminate them.